Notice Regarding Revision of Full-Year Consolidated Financial Forecasts
Filed with TSE · · 2 pages · English
Summary by 6ix AI
The revision is due to expected gains from the sale of investment securities, which will increase profit attributable to owners of the parent beyond previous estimates. The company emphasizes that these forecasts are based on current information and actual results may vary due to future factors.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Medipal Holdings Corporation on 6ix
Earlier from Medipal
- Notice Regarding Setting of Record Date for Convocation of an Extraordinary General Meeting of Shareholders
- Notice Regarding Changes of Representative Directors and Directors
- Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2027
- Notice Regarding Results of the Tender Offer for Shares of PALTAC CORPORATION (Securities Code: 8283)
- Medipal Holdings: Consolidated Financial Statements for the Fiscal Year Ended March 31, 2026
Later from Medipal
- Notice Regarding Shareholder’s Petition for Permission to Convene an Extraordinary General Meeting of Shareholders
- Consolidated Financial Statements for the Second Quarter (Interim Period) of the Fiscal Year Ending March 31, 2027
- Initiatives for Medium- to Long-Term Enhancement of Corporate Value
- Notice Regarding Holding of an Extraordinary General Meeting of Shareholders and Opinion of the Company’s Board of Directors on Shareholder Proposal
- Notice Regarding Partial Amendments to the Articles of Incorporation
Follow Medipal into a list and get an email when it puts out news.
Follow Medipal